Lumora

Company Overview

Snapshot

Founded in September 2025, Lumora operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its AI agent for clinical trial data validation.

Business overview

Lumora develops an AI agent designed to automate the end-to-end validation of clinical and trial data within the Health Tech & Life Sciences sector, specifically targeting Digital Healthcare and Clinical Workflow. The platform ingests medical records and source files, learns study-specific datasets and rules, and generates protocol-aligned validation test plans. It autonomously detects data errors, traces them to originating documents, and suggests fixes, aiming to replace manual review processes with automated analysis for clinical operations and data management teams. This B2B solution seeks to reduce data-cleaning cycles, improve data quality, and accelerate regulatory readiness for sponsors and Contract Research Organizations (CROs).

Company Intelligence Q&A

What is Lumora's primary focus?

Lumora's primary focus is on developing an AI agent that automates the end-to-end validation of clinical and trial data, aiming to streamline data management processes for clinical operations.

When was Lumora founded?

Lumora was founded in September 2025.

What problem does Lumora's technology address?

Lumora's technology addresses the challenge of manual clinical trial data validation by automating error detection, tracing, and suggesting fixes, thereby reducing data-cleaning cycles and improving data quality.

Which industries does Lumora serve?

Lumora serves the Health Tech & Life Sciences sector, with a specific focus on Digital Healthcare and Clinical Workflow, providing solutions for sponsors and CROs.

What is the current product stage of Lumora's AI agent?

Lumora's AI agent for automated validation of clinical trial data is currently in its Beta product stage.